Literature DB >> 26261683

Cross-talk between TGF-β/Smad pathway and Wnt/β-catenin pathway in pathological scar formation.

Qiang Sun1, Shu Guo1, Chen-Chao Wang1, Xu Sun1, Di Wang1, Nan Xu1, Shi-Feng Jin1, Ke-Zhu Li1.   

Abstract

TGF-β1 is a key factor in the process of wound healing, which is regulated by TGF-β/Smad pathway. We previously demonstrated that TGF-β1 contributed to pathological scar formation. And previous studies also suggested Wnt/β-catenin pathway might be involved in wound healing. However, their role and relation in pathological scar formation remains not very clear. For evaluating TGF-β1 and β-catenin, key factors of the two signal pathways, immunohistochemistry, western blot analysis and RT-PCR were used. Simultaneously, immunohistochemistry were used to evaluate Smad2, Smad3 and Wnt-1, which were also the important factors. We found that they all significantly accumulated in pathological scars compared with normal skins (P<0.05), that implied the two signal pathways both contributed to pathological scar formation. Meanwhile, β-catenin expression showed a tendency to increase first and then decrease under the influence of different concentrations of TGF-β1 (P<0.01). It is possible that there is a complicated interaction between the two signal pathways in pathological scar formation (both synergy and antagonism).

Entities:  

Keywords:  TGF-β/Smad pathway; Wnt/β-catenin pathway; pathological scar

Mesh:

Substances:

Year:  2015        PMID: 26261683      PMCID: PMC4526017     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  24 in total

Review 1.  International clinical recommendations on scar management.

Authors:  Thomas A Mustoe; Rodney D Cooter; Michael H Gold; F D Richard Hobbs; Albert-Adrien Ramelet; Peter G Shakespeare; Maurizio Stella; Luc Téot; Fiona M Wood; Ulrich E Ziegler
Journal:  Plast Reconstr Surg       Date:  2002-08       Impact factor: 4.730

2.  The beta-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells.

Authors:  Marc van de Wetering; Elena Sancho; Cornelis Verweij; Wim de Lau; Irma Oving; Adam Hurlstone; Karin van der Horn; Eduard Batlle; Damien Coudreuse; Anna Pavlina Haramis; Menno Tjon-Pon-Fong; Petra Moerer; Maaike van den Born; Gwen Soete; Steven Pals; Martin Eilers; Rene Medema; Hans Clevers
Journal:  Cell       Date:  2002-10-18       Impact factor: 41.582

3.  TC-1 (c8orf4) enhances aggressive biologic behavior in lung cancer through the Wnt/β-catenin pathway.

Authors:  Kai Su; Lijun Huang; Wenhai Li; Xiaolong Yan; Xiaofei Li; Zhipei Zhang; Faguang Jin; Jie Lei; Guangzhen Ba; Boya Liu; Xiaoping Wang; Yunjie Wang
Journal:  J Surg Res       Date:  2013-06-11       Impact factor: 2.192

4.  Beta-catenin regulates wound size and mediates the effect of TGF-beta in cutaneous healing.

Authors:  Sophia S Cheon; Qingxia Wei; Ananta Gurung; Andrew Youn; Tamara Bright; Raymond Poon; Heather Whetstone; Abhijit Guha; Benjamin A Alman
Journal:  FASEB J       Date:  2006-04       Impact factor: 5.191

5.  The effects of myostatin on adipogenic differentiation of human bone marrow-derived mesenchymal stem cells are mediated through cross-communication between Smad3 and Wnt/beta-catenin signaling pathways.

Authors:  Wen Guo; John Flanagan; Ravi Jasuja; James Kirkland; Lan Jiang; Shalender Bhasin
Journal:  J Biol Chem       Date:  2008-01-18       Impact factor: 5.157

6.  Genetic susceptibility to keloid disease: transforming growth factor beta receptor gene polymorphisms are not associated with keloid disease.

Authors:  Ardeshir Bayat; O Bock; U Mrowietz; W E R Ollier; M W J Ferguson
Journal:  Exp Dermatol       Date:  2004-02       Impact factor: 3.960

Review 7.  TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing.

Authors:  Meinhard Schiller; Delphine Javelaud; Alain Mauviel
Journal:  J Dermatol Sci       Date:  2004-08       Impact factor: 4.563

8.  Smad2 functions as a co-activator of canonical Wnt/beta-catenin signaling pathway independent of Smad4 through histone acetyltransferase activity of p300.

Authors:  Morihisa Hirota; Kazuhide Watanabe; Shin Hamada; Youping Sun; Luigi Strizzi; Mario Mancino; Tadahiro Nagaoka; Monica Gonzales; Masaharu Seno; Caterina Bianco; David S Salomon
Journal:  Cell Signal       Date:  2008-05-18       Impact factor: 4.315

9.  Equine ANXA2 and MMP1 expression analyses in an experimental model of normal and pathological wound repair.

Authors:  Vincenzo Miragliotta; Josiane Lefebvre-Lavoie; Jacques G Lussier; Christine L Theoret
Journal:  J Dermatol Sci       Date:  2008-04-22       Impact factor: 4.563

10.  Fibroblast migration is mediated by CD44-dependent TGF beta activation.

Authors:  Pinak S Acharya; Sonali Majumdar; Michele Jacob; James Hayden; Paul Mrass; Wolfgang Weninger; Richard K Assoian; Ellen Puré
Journal:  J Cell Sci       Date:  2008-04-08       Impact factor: 5.285

View more
  10 in total

1.  MicroRNA Profiling in Aging Brain of PSEN1/PSEN2 Double Knockout Mice.

Authors:  Suji Ham; Tae Kyoo Kim; Sangjoon Lee; Ya-Ping Tang; Heh-In Im
Journal:  Mol Neurobiol       Date:  2017-09-06       Impact factor: 5.590

Review 2.  Distinct Roles of Wnt/β-Catenin Signaling in the Pathogenesis of Chronic Obstructive Pulmonary Disease and Idiopathic Pulmonary Fibrosis.

Authors:  Juan Shi; Feng Li; Meihui Luo; Jun Wei; Xiaoming Liu
Journal:  Mediators Inflamm       Date:  2017-05-09       Impact factor: 4.711

Review 3.  Biological approaches for hypertrophic scars.

Authors:  Zhong Lingzhi; Li Meirong; Fu Xiaobing
Journal:  Int Wound J       Date:  2019-12-20       Impact factor: 3.315

4.  Expression of TGF-β1/mTOR signaling pathway in pathological scar fibroblasts.

Authors:  Xiao-Xiang Zhai; Zhi-Ming Tang; Ji-Cun Ding; Xiao-Lan Lu
Journal:  Mol Med Rep       Date:  2017-04-05       Impact factor: 2.952

5.  Expression of mTOR/70S6K signaling pathway in pathological scar fibroblasts and the effects of resveratrol intervention.

Authors:  Zhi-Ming Tang; Xiao-Xiang Zhai; Ji-Cun Ding
Journal:  Mol Med Rep       Date:  2017-03-16       Impact factor: 2.952

6.  Valproic Acid Induces Endothelial-to-Mesenchymal Transition-Like Phenotypic Switching.

Authors:  Shamini Murugavel; Antoinette Bugyei-Twum; Pratiek N Matkar; Husain Al-Mubarak; Hao H Chen; Mohamed Adam; Shubha Jain; Tanya Narang; Rawand M Abdin; Mohammad Qadura; Kim A Connelly; Howard Leong-Poi; Krishna K Singh
Journal:  Front Pharmacol       Date:  2018-07-11       Impact factor: 5.810

7.  CEMIP (KIAA1199) induces a fibrosis-like process in osteoarthritic chondrocytes.

Authors:  Céline Deroyer; Edith Charlier; Sophie Neuville; Olivier Malaise; Philippe Gillet; William Kurth; Alain Chariot; Michel Malaise; Dominique de Seny
Journal:  Cell Death Dis       Date:  2019-02-04       Impact factor: 8.469

Review 8.  Current Therapeutic Approach to Hypertrophic Scars.

Authors:  Zrinka Bukvić Mokos; Anamaria Jović; Lovorka Grgurević; Ivo Dumić-Čule; Krešimir Kostović; Romana Čeović; Branka Marinović
Journal:  Front Med (Lausanne)       Date:  2017-06-20

9.  Aberrantly expressed long noncoding RNAs in hypertrophic scar fibroblasts in vitro: A microarray study.

Authors:  Longxiang Tu; Qi Huang; Shangfeng Fu; Dewu Liu
Journal:  Int J Mol Med       Date:  2018-01-26       Impact factor: 4.101

Review 10.  Rational selection of bioactive principles for wound healing applications: Growth factors and antioxidants.

Authors:  Pamela Viaña-Mendieta; Mirna Lorena Sánchez; Jorge Benavides
Journal:  Int Wound J       Date:  2021-05-05       Impact factor: 3.315

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.